Jin Zhang

Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher‐risk myelodysplastic syndromes: a prospective multicenter single‐arm trial

Jie Jin, Yue-min Kuang, Yanling Ren, 2020, Hematological oncology.

Oxidative stress response induced by chemotherapy in leukemia treatment

Shibing Wang, W. Qian, Jin Zhang, 2018, Molecular and clinical oncology.

Targeting the CD47-SIRPα signaling axis: current studies on B-cell lymphoma immunotherapy

W. Qian, Jin Zhang, Xiaojun Guo, 2018, The Journal of international medical research.

PDK1 inhibitor GSK2334470 synergizes with proteasome inhibitor MG‑132 in multiple myeloma cells by inhibiting full AKT activity and increasing nuclear accumulation of the PTEN protein.

Chunmei Yang, Jin Zhang, Xiaohui Chen, 2018, Oncology reports.

Early Death and Survival of Patients With Acute Promyelocytic Leukemia in ATRA Plus Arsenic Era: A Population-Based Study

Wen-da Luo, Chun-Mei Chen, Jian Huang, 2021, Frontiers in Oncology.

Salvage tigecycline in high risk febrile neutropenic patients with hematological malignancies: a prospective multicenter study

H. Tong, Li Li, X. Ye, 2018, Leukemia & lymphoma.

Empirical polymyxin B therapy in febrile neutropenic patients with hematological diseases: A prospective, multicenter, observational clinical study.

Jianping Shen, Chao Hu, Xinping Zhou, 2023, The Journal of infection.

USP14 promotes the malignant progression and ibrutinib resistance of mantle cell lymphoma by stabilizing XPO1

Ye Zhang, Jin Zhang, Shenhe Jin, 2023, International journal of medical sciences.